Calidi Biotherapeutics, Inc. (CLDI)
0.7946
-0.05
(-6.07%)
USD |
NYAM |
Feb 27, 16:00
0.79
0.00 (0.00%)
After-Hours: 20:00
Calidi Biotherapeutics Total Liabilities (Quarterly) : 6.831M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
| Savara, Inc. | 46.54M |
| BioMarin Pharmaceutical, Inc. | 1.507B |
| Imunon, Inc. | 4.906M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.03M |
| Shareholders Equity (Quarterly) | 6.918M |
| Debt to Equity Ratio | 0.4782 |
| Current Ratio | 2.124 |
| Net Debt Paydown Yield | 10.34% |